FDA Approves J&J's Imaavy for Rare Blood Disorder

The U.S. Food and Drug Administration (FDA) has granted approval to Johnson & Johnson's drug Imaavy. This new treatment is approved for warm autoimmune hemolytic anemia, a rare blood disorder.